30
Participants
Start Date
April 30, 2002
Primary Completion Date
May 31, 2004
Study Completion Date
May 31, 2004
natalizumab
University of Rochester, Rochester
Hershey Medical Center, Hershey
Carolina Digestive Health Associates, Charlotte
Miami Research Associates, Miami
Medical College of Wisconsin, Milwaukee
Cedars-Sinai IBD Center, Los Angeles
Connecticut Children's Medical Center, Hartford
Johns Hopkins University School of Medicine, Baltimore
Mass General Hospital for Children, Pediatric GI & Nutrition, Boston
The Children's Hospital, Boston
Children's Hospital of Philadelphia, Philadelphia
Royal Hospital for Sick Children, Edinburgh
Royal Free Medical School, London
Lead Sponsor
Collaborators (1)
Elan Pharmaceuticals
INDUSTRY
Biogen
INDUSTRY